Application of T-SPOT.TB in the Diagnosis of Cutaneous Mycobacterium marinum Infections and Evaluation of Treatment Efficacy
Acta Dermato-Venereologica · 2025
DOI: 10.2340/actadv.v105.44119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Dermato-Venereologica, 2025. Verfasst von Chen Cen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Zhejiang Provincial Dermatology Hospital, Huzhou, China. Hauptthemen laut MEDLINE: Mycobacterium Infections, Nontuberculous, Mycobacterium marinum, Interferon-gamma Release Tests, Skin Diseases, Bacterial. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This study evaluated the diagnostic value and therapeutic efficacy assessment potential of the interferon-γ release assay T-SPOT.TB in cutaneous Mycobacterium marinum infections. A total of 145 patients diagnosed at the Institute of Dermatology, Chinese Academy of Medical Sciences (2020–2024), excluding tuberculosis cases, were retrospectively analysed. Clinical data including demographics, underlying diseases, pathology, microbiological culture, molecular identification, T-SPOT.TB results, treatment regimens, and outcomes were collected. T-SPOT.TB results before treatment, and at 3 and 6 months post-treatment, were compared to assess its diagnostic and monitoring utility. The baseline T-SPOT.TB positivity rate was 71% (95% CI: 63.2–77.8%). Among 17 patients retested at 3 months, positivity was 64.7% (p = 0.125), with median spot-forming cells (SFCs) significantly decreasing from 20.0 (IQR 8.5–41.0) to 8.0 (IQR 2.5–28.0) (p = 0.0007). Among 27 patients retested at 6 months, positivity was 59.3% (p = 0.344), with median SFCs decreasing from 12.0 (IQR 5.0–30.0) to 8.0 (IQR 3.0–13.0) (p = 0.0006). No significant difference in positivity rates was observed between 3 and 6 months post-treatment. The T-SPOT.TB assay shows significant diagnostic value for cutaneous M. marinum infections and facilitates early diagnosis. Declining SFC counts post-treatment provide useful reference for evaluating therapeutic response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Zhejiang Provincial Dermatology Hospital, Huzhou, China.
- Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.
- Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China. whs33@vip.sina.com.
- Department of Dermatology, Zhejiang Provincial Dermatology Hospital, Huzhou, China. 358606498@qq.com.
Zitieren
APA
Cen, C., Xie, B., Zeng, R., Zhang, W., Wang, H., & Sang, X. (2025). Application of T-SPOT.TB in the Diagnosis of Cutaneous Mycobacterium marinum Infections and Evaluation of Treatment Efficacy. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v105.44119
Vancouver
Cen C, Xie B, Zeng R, Zhang W, Wang H, Sang X. Application of T-SPOT.TB in the Diagnosis of Cutaneous Mycobacterium marinum Infections and Evaluation of Treatment Efficacy. Acta Dermato-Venereologica. 2025. doi:10.2340/actadv.v105.44119
BibTeX
@article{Cen2025,
author = {Cen, Chen and Xie, Bibo and Zeng, Rui and Zhang, Wenyue and Wang, Hongsheng and Sang, Xudong},
title = {Application of T-SPOT.TB in the Diagnosis of Cutaneous Mycobacterium marinum Infections and Evaluation of Treatment Efficacy},
journal = {Acta Dermato-Venereologica},
year = {2025},
doi = {10.2340/actadv.v105.44119}
}
EUVIMED